Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Treatment options for mild to moderate ulcerative colitis (UC) that do not respond to 5-ASA are limited. MH002, a consortium of six non-pathogenic commensal bacteria, offers immune modulation, wound healing, and gut barrier protection. The study assessed the safety, efficacy, and mechanisms of MH002 in treating mild to moderate UC (1)
A randomized, double-blind, placebo-controlled treatment trial evaluating MH002 or placebo in 45 patients with mild to moderate active Ulcerative colitis (UC) (1)